Curie: The Oncology Brief

Love what you hear? Download the Curie app from the App Store today . Curie is your personalized, expert-driven healthcare podcast platform—offering in-depth analysis, timely insights, and discussions tailored for medical professionals. In this episode of Curie, Matt covers three key updates in oncology. A new analysis shows that radiation oncology practices are consolidating rapidly, raising conc...

Love what you hear? Download the Curie app from the App Store today . Curie is your personalized, expert-driven healthcare podcast platform—offering in-depth analysis, timely insights, and discussions tailored for medical professionals. In this episode of Curie, Matt covers three important topics shaping cancer care. A new study confirms that achieving MRD negativity early in AML is critical for l...

In this episode of Curie , Matt covers three major developments in oncology. The FDA has approved datopotamab deruxtecan (Datroway) for HR positive, HER2 negative breast cancer, marking a new era for antibody-drug conjugates in this disease. A meta-analysis suggests that the timing of immunotherapy infusions may impact survival outcomes, raising questions about how circadian rhythms influence trea...

In this episode of Curie , Matt breaks down three major updates in oncology. ASCO has released updated guidelines for advanced ovarian cancer, emphasizing primary cytoreductive surgery over neoadjuvant chemotherapy when feasible. The Mammo-50 trial challenges the standard of annual mammographic surveillance for breast cancer survivors over 50, showing that less frequent screening is non-inferior....

Love what you hear? Download the Curie app from the App Store today . Curie is your personalized, expert-driven healthcare podcast platform—offering in-depth analysis, timely insights, and discussions tailored for medical professionals. In this episode of Curie , Matt covers three major updates in oncology. Vimseltinib (Romvimza) has been FDA-approved for tenosynovial giant cell tumors (TGCT), pro...

Love what you hear? Download the Curie app from the App Store today . Curie is your personalized, expert-driven healthcare podcast platform—offering in-depth analysis, timely insights, and discussions tailored for medical professionals. In this episode of Curie , Matt breaks down three critical updates in oncology. A new study links declining PSA screening rates to a rise in advanced prostate canc...

Love what you hear? Download the Curie app from the App Store today . Curie is your personalized, expert-driven healthcare podcast platform—offering in-depth analysis, timely insights, and discussions tailored for medical professionals. In this episode of Curie , Matt explores game-changing developments in oncology. Learn about the latest chemotherapy-free approach for HER2-mutated metastatic brea...

Love what you hear? Download the Curie app from the App Store today . Curie is your personalized, expert-driven healthcare podcast platform—offering in-depth analysis, timely insights, and discussions tailored for medical professionals. From nivolumab-plus-ipilimumab in colorectal cancer to the latest CAR-T therapies in GI malignancies, explore the cutting-edge breakthroughs from ASCO GI 2025. Thi...

Love what you hear? Download the Curie app from the App Store today . Curie is your personalized, expert-driven healthcare podcast platform—offering in-depth analysis, timely insights, and discussions tailored for medical professionals. In this episode of Curie, Matt explores the latest breakthroughs and challenges in oncology care. Learn about novel immunotherapy combinations offering new hope fo...

Love what you hear? Download the Curie app from the App Store today . Curie is your personalized, expert-driven healthcare podcast platform—offering in-depth analysis, timely insights, and discussions tailored for medical professionals. In this episode of Curie , Matt uncovers the nuanced relationship between red wine and cancer risk, separating myths from evidence. We then dive into the promising...

Love what you hear? Download the Curie app from the App Store today . Curie is your personalized, expert-driven healthcare podcast platform—offering in-depth analysis, timely insights, and discussions tailored for medical professionals. In this episode of Curie , Matt explores the latest in oncology. Discover how cetuximab outperformed immunotherapy in head and neck cancer, easing treatment decisi...

Love what you hear? Download the Curie app from the App Store today . Curie is your personalized, expert-driven healthcare podcast platform—offering in-depth analysis, timely insights, and discussions tailored for medical professionals. In this episode of Curie , Matt delves into three groundbreaking developments. Discover how MRI-guided SBRT is transforming prostate cancer care with fewer side ef...

Love what you hear? Download the Curie app from the App Store today . Curie is your personalized, expert-driven healthcare podcast platform—offering in-depth analysis, timely insights, and discussions tailored for medical professionals. Join us as we wrap up ASH 2024, highlighting transformative breakthroughs like menin inhibitors in AML, advancements in gene editing for sickle cell disease, and g...

Love what you hear? Download the Curie app from the App Store today . Curie is your personalized, expert-driven healthcare podcast platform—offering in-depth analysis, timely insights, and discussions tailored for medical professionals. On Day 4 of ASH 2024, explore the remarkable 96% disease-free survival with Blincyto in pediatric ALL, deep responses with Epcoritamab in relapsed CLL, and the pro...

Love what you hear? Download the Curie app from the App Store today . Curie is your personalized, expert-driven healthcare podcast platform—offering in-depth analysis, timely insights, and discussions tailored for medical professionals. Day 3 of ASH 2024 revealed groundbreaking findings: a 97% complete response rate for zilovertamab vedotin in diffuse large B-cell lymphoma, new insights into zanub...

Love what you hear? Download the Curie app from the App Store today . Curie is your personalized, expert-driven healthcare podcast platform—offering in-depth analysis, timely insights, and discussions tailored for medical professionals. On Day 2 of ASH 2024, we explore breakthroughs in treating high-risk smoldering multiple myeloma, advancements in chronic lymphocytic leukemia therapies, and a rev...

Love what you hear? Download the Curie app from the App Store today . Curie is your personalized, expert-driven healthcare podcast platform—offering in-depth analysis, timely insights, and discussions tailored for medical professionals. Dive into Day 1 of ASH 2024 with Curie . In this episode, we discuss key takeaways from groundbreaking studies, including etavopivat’s promising results for sickle...

Prepare for ASH 2024 with this in-depth preview! In this episode, Matt dives into the conference’s overarching themes, from artificial intelligence and cellular therapies to health equity and novel drug advancements. He also shares practical tips to help you make the most of the event. Here’s a list of the key sessions and presenters mentioned in this episode: The Application of Artificial Intelli...

Love what you hear? Download the Curie app from the App Store today . Curie is your personalized, expert-driven healthcare podcast platform—offering in-depth analysis, timely insights, and discussions tailored for medical professionals. Join us as we unpack the debate on breast cancer screening guidelines, explore PI3K inhibitors in advanced breast cancer, and examine AI’s role in rare cancer diag...

Love what you hear? Download the Curie app from the App Store today . Curie is your personalized, expert-driven healthcare podcast platform—offering in-depth analysis, timely insights, and discussions tailored for medical professionals. Dr. Goldfarb, your request led us to this deep dive into the evolving treatment landscape of rectal cancer. In this episode of Ask Curie , we explore non-operative...